Ocular Therapeutix Competitors and Similar CompaniesClear all

Ocular Therapeutix's competitors and similar companies include Mati Therapeutics, Opthea, Calliditas Therapeutics and CSL Behring.

	Ocular Therapeutix Ocular Therapeutix develops and commercializes ophthalmic therapeutic products by using hydrogel technology.	Mati Therapeutics Mati Therapeutics is a company that develops a non-invasive sustained drug delivery platform.	Opthea Opthea (formerly Circadian Technologies) is a biopharmaceutical company developing a therapy for the treatment of retinal diseases.	Calliditas Therapeutics Calliditas Therapeutics is a biopharmaceutical company focused on identifying, developing, and commercializing treatments in orphan indications.	CSL Behring CSL Behring is a provider of life-saving medicines.
Founding Date	Founding Date 2006	Founding Date 2012	Founding Date 2012	Founding Date 2004	Founding Date 1904
Type	Type Public	Type Private	Type Public	Type Public	Type Subsidiary
Tags	Tags Healthcare biotech drug development pharma	Tags Healthcare medical devices therapy	Tags Healthcare biotech drug development therapy	Tags Healthcare biotech pharma	Tags Healthcare biotech drug development pharma
Locations	Locations Bedford, US HQ Bedford, US Bedford, US	Locations Austin, US HQ Burnaby, CA	Locations South Yarra, AU HQ Toorak, AU	Locations Stockholm, SE HQ Archamps, FR Stockholm, SE Stockholm, SE Plan Les Ouates, CH Hoboken, US New York, US	Locations King of Prussia, US HQ Broadmeadows, AU Parkville, AU Parkville, AU Wien, AT Mechelen, BE see more
Employees	Employees 16740% increase	Employees N/A	Employees 33	Employees 2221% increase	Employees 7,5692% decrease
Valuation ($)	Valuation ($) 1.8 b	Valuation ($) N/A	Valuation ($) 711.2 m	Valuation ($) 1.1 b	Valuation ($) N/A
Financial
Revenue (est.)	Revenue (est.) $52m (FY, 2025)	Revenue (est.) N/A	Revenue (est.) $25k (FY, 2025)	Revenue (est.) kr1.2b (FY, 2023)	Revenue (est.) $7.9b (FY, 2020)
Cost of goods	Cost of goods $6.6m (FY, 2025)	Cost of goods N/A	Cost of goods N/A	Cost of goods kr60.5m (FY, 2023)	Cost of goods N/A
Gross profit	Gross profit $45.4m (FY, 2025)	Gross profit N/A	Gross profit $146k (FY, 2025)	Gross profit kr1.2b (FY, 2023)	Gross profit $4.5b (FY, 2020)
Net income	Net income ($265.9m) (FY, 2025)	Net income N/A	Net income ($162.8m) (FY, 2025)	Net income (kr466.2m) (FY, 2023)	Net income N/A
Funding
Total funding raised	Total funding raised $ 73.3m	Total funding raised $ 1.6m	Total funding raised $ 67.6m	Total funding raised $ 33.2m	Total funding raised N/A